Animal Biotechnology Market Outlook 2026-2034: by Product Type (Biologics, Diagnostics, Drugs, Nutrition, Reproductive & Genetic), Animal Type, Application, End-User

The Animal Biotechnology Market is estimated at US$30 billion in 2026 and is projected to grow at a CAGR of 7.5% to reach US$53.5 billion by 2034.

Market Overview

The global animal biotechnology market includes biotechnology tools and products used to improve animal health, breeding, diagnostics, vaccines, genetics, and advanced veterinary treatment outcomes. The value chain spans research institutions, gene and cell technology developers, diagnostic manufacturers, biologics producers, veterinary distributors, and livestock or companion care providers.

Major end uses include animal vaccines, genetic improvement, disease diagnostics, reproductive support, and advanced veterinary therapeutics. Demand reflects the need for healthier herds and pets, food security priorities, and rising investment in advanced veterinary science.

Market Segmentation

By Product Type

• Biologics
• Diagnostics
• Drugs
• Nutrition
• Reproductive & Genetic

By Animal Type

• Livestock Animals
• Companion Animals

By Application

• Disease Diagnosis
• Preventive Care & Treatment
• Research & Development

By End-User

• Laboratories
• Point-of-care testing
• Veterinary Hospitals & Clinics
• Other End-Users

Key Companies Analysed

• Zoetis
• Elanco
• Boehringer Ingelheim Animal Health
• Merck Animal Health
• Ceva Sante Animale
• Virbac
• Phibro Animal Health
• Neogen
• IDEXX Laboratories
• HIPRA
• Biogenesis Bago
• Heska
• Vetoquinol
• Indian Immunologicals
• KRKA
• Dechra Pharmaceuticals
• Anicon Labor
• Thermo Fisher Scientific
• QIAGEN
• Agilent Technologies

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.